Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Therapeutic Drug Monitoring|August 1, 1992
Predictive performance of Bayesian and nonlinear least-squares regression programs for lidocaineC J Destache, D E Hilleman, S J Mohiuddin, et al.Drug Intelligence & Clinical Pharmacy|September 1, 1985
Lidocaine-induced second-degree mobitz type II heart blockD E Hilleman, S M Mohiuddin, C J DestachePharmacotherapy|September 19, 2001
Potential influence of timing of low-density lipoprotein cholesterol evaluation in patients with acute coronary syndromeM A Faulkner, D E Hilleman, C J Destache, et al.Journal of Clinical Pharmacology|April 1, 1991
Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteersA M Stoysich, S M Mohiuddin, C J Destache, et al.Drug Intelligence & Clinical Pharmacy|July 1, 1988
Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmiasD E Hilleman, A J Patterson, S M Mohiuddin, et al.Journal of Clinical Pharmacology|September 1, 1992
Impact of food on the bioavailability of encainideD E Hilleman, S M Mohiuddin, C J Destache, et al.The Annals of Pharmacotherapy|June 11, 1992
Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmiasD E Hilleman, S M Mohiuddin, A N Mooss, et al.American Heart Journal|March 11, 1992
Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolismS M Mohiuddin, D E Hilleman, C J Destache, et al.DICP : the Annals of Pharmacotherapy|March 1, 1991
Pharmacokinetic and tolerance evaluation of actisomide, a new antiarrhythmic agent, in healthy volunteersM A Malesker, S M Mohiuddin, C J Destache, et al.Therapeutic Drug Monitoring|December 1, 1993
Use of therapeutic drug monitoring in pharmacoeconomicsC J DestachePageof 11